Quantbot Technologies LP Glycomimetics Inc Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.07 - $5.0 $6,140 - $10,000	-2,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.06 - $3.76 $4,120 - $7,520	2,000 New	2,000 $7,000
Q2 2018 Aug 13, 2018	SELL	$14.63 - $19.19 $17,248 - $22,625	-1,179 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$16.06 - $25.35 $106,831 - $168,628	-6,652 Reduced 84.94%	1,179 $19,000
Q4 2017 Feb 12, 2018	BUY	$10.51 - $17.22 $82,303 - $134,849	7,831	7,831 $131,000

27.3M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $15.2M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.